Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

ClinicalTrials.gov ID: NCT01955109

Public ClinicalTrials.gov record NCT01955109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut

Study identification

NCT ID
NCT01955109
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
DBV Technologies
Industry
Enrollment
171 participants

Conditions and interventions

Conditions

Interventions

  • Viaskin Peanut 250 mcg Biological

Biological

Eligibility (public fields only)

Age range
7 Years to 56 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2013
Primary completion
Aug 31, 2016
Completion
Aug 31, 2016
Last update posted
Jun 29, 2022

2013 – 2016

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
University of California, Rady Childrens Hospital San Diego California 92123
Stanford University School of Medicine Stanford California 94305
Children's Memorial Hospital Chicago Illinois 60611
Massachusetts General Hospital Boston Massachusetts 02114
Boston Childrens' Hospital Boston Massachusetts 02115
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Children's Medical Center Dallas Dallas Texas 75235
ASTHMA, Inc. Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01955109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2022 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01955109 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →